Nitetime Cold And Flu

Nitetime Cold And Flu Manufacturers

• Equate (Walmart Stores, Inc.)
  

  ×

  Nitetime Cold And Flu | Equate (walmart Stores, Inc.)

  

  ---

  take only as recommended (see overdose warning) do not exceed 4 doses per 24 hours use dosing cup provided tbsp=tablespoon, mL= milliliter  age dose adults & children 12 yrs and over 2 tablespoons (30 mL) every 6 hours children 4 to 11 yrs do not use unless directed by a doctor children under 4 yrs do not use When using other Day Time or Night Time products, carefully read each label to insure correct dosing

  Close
  No Recall

  More Info
• Meijer Distribution Inc
  

  ×

  Nitetime Cold And Flu | Meijer Distribution Inc

  

  ---

  • take only as directed – see Liver warning • do not exceed 8 softgels per 24 hours

  adults & children 12 yrs & over

  2 softgels with water every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  • when using other Daytime or Nighttime products, carefully read each label to insure correct dosing

  Close
  No Recall

  More Info
• Kroger Company
  

  ×

  Nitetime Cold And Flu | Kroger Company

  

  ---

  • take only as directed – see Liver warning • do not exceed 8 softgels per 24 hours

  adults & children 12 yrs & over

  2 softgels with water every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  • when using other Daytime or Nighttime products, carefully read each label to insure correct dosing

  Close
  No Recall

  More Info
• Meijer Distribution Inc
  

  ×

  Nitetime Cold And Flu | Meijer Distribution Inc

  

  ---

  • take only as directed – see Liver warning • do not exceed 8 softgels per 24 hours

  adults & children 12 yrs & over

  2 softgels with water every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  • when using other Daytime or Nighttime products, carefully read each label to insure correct dosing

  Close
  No Recall

  More Info
• Meijer Distribution Inc
  

  ×

  Nitetime Cold And Flu | H E B

  

  ---

  • do not use more than directed (see overdose warning) • take every 4 hours, while symptoms persist. Do not take more than 5 packets in 24 hours unless directed by a doctor.

  Age

  Dose

  children under 4 years of age

  do not use

  children 4 to under 12 years of age

  do not use unless directed by a doctor

  adults and children 12 years of age and over

  one packet

  • dissolve contents of one packet into 8 oz. hot water: sip while hot. Consume entire drink within 10-15 minutes. • if using a microwave, add contents of one packet to 8 oz. of cool water: stir briskly before and after heating. Do not overheat.

  Close
  No Recall

  More Info
• Meijer Distribution Inc
  

  ×

  Nitetime Cold And Flu | Sagent Pharmaceuticals

  

  ---

  2.1 Dosage in Adult Patients with Normal Renal Function

  The usual dose of Levofloxacin Injection is 250 mg or 500 mg administered by slow infusion over 60 minutes every 24 hours or 750 mg administered by slow infusion over 90 minutes every 24 hours, as indicated by infection and described in Table 1.

  These recommendations apply to patients with creatinine clearance ≥ 50 mL/min. For patients with creatinine clearance <50 mL/min, adjustments to the dosing regimen are required [see Dosage and Administration (2.3)].

  Table 1: Dosage in Adult Patients with Normal Renal Function (creatinine clearance ≥ 50mL/min)

  1 Due to the designated pathogens [see Indications and Usage (1)].

  2 Sequential therapy (intravenous to oral) may be instituted at the discretion of the physician.

  3 Due to methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae (including multi-drug-resistant isolates [MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydophila pneumoniae, Legionella pneumophila, or Mycoplasma pneumoniae [see Indications and Usage (1.2)].

  4 Due to Streptococcus pneumoniae (excluding multi-drug-resistant isolates [MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Mycoplasma pneumoniae, or Chlamydophila pneumoniae [see Indications and Usage (1.3)].

  5 This regimen is indicated for cUTI due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and AP due to E. coli, including cases with concurrent bacteremia.

  6 This regimen is indicated for cUTI due to Enterococcus faecalis, Enterococcus cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa; and for AP due to E. coli.

  7 Drug administration should begin as soon as possible after suspected or confirmed exposure to aerosolized B. anthracis. This indication is based on a surrogate endpoint. Levofloxacin plasma concentrations achieved in humans are reasonably likely to predict clinical benefit [see Clinical Studies (14.9)].

  8 The safety of levofloxacin in adults for durations of therapy beyond 28 days or in pediatric patients for durations beyond 14 days has not been studied. An increased incidence of musculoskeletal adverse events compared to controls has been observed in pediatric patients [see Warnings and Precautions (5.10), Use in Specific Populations (8.4), and Clinical Studies (14.9)]. Prolonged levofloxacin therapy should only be used when the benefit outweighs the risk.

  9 Drug administration should begin as soon as possible after suspected or confirmed exposure to Yersinia pestis. Higher doses of levofloxacin typically used for treatment of pneumonia can be used for treatment of plague, if clinically indicated.

  Type of Infection1 Dosed Every 24 hours Duration (days)2 Nosocomial Pneumonia 750 mg 7-14 Community Acquired Pneumonia3 500 mg 7-14 Community Acquired Pneumonia4 750 mg 5 Acute Bacterial Sinusitis 750 mg 5 500 mg 10-14 Acute Bacterial Exacerbation of Chronic Bronchitis 500 mg 7 Complicated Skin and Skin Structure Infections (SSSI) 750 mg 7-14 Uncomplicated SSSI 500 mg 7-10 Chronic Bacterial Prostatitis 500 mg 28 Complicated Urinary Tract Infection (cUTI) or
  Acute Pyelonephritis (AP)5 750 mg 5 Complicated Urinary Tract Infection (cUTI) or
  Acute Pyelonephritis (AP)6 250 mg 10
  Uncomplicated Urinary Tract Infection 250 mg 3 Inhalational Anthrax (Post-Exposure), adult and pediatric patients > 50 kg7,8
  Pediatric patients < 50 kg and ≥ 6 months of age7,8 500 mg
  See Table 2 below (2.2) 608
  608 Plague, adult and pediatric patients > 50 kg9
  Pediatric patients < 50 kg and ≥ 6 months of age 500 mg
  see Table 2 below (2.2) 10 to 14
  10 to 14 2.2 Dosage in Pediatric Patients

  The dosage in pediatric patients ≥ 6 months of age is described below in Table 2.

  Table 2: Dosage in Pediatric Patients ≥ 6 months of age

  1 Due to Bacillus anthracis [see Indications and Usage (1.13)] and Yersinia pestis [see Indications and Usage (1.14)].

  2 Sequential therapy (intravenous to oral) may be instituted at the discretion of the physician.

  3 Drug administration should begin as soon as possible after suspected or confirmed exposure to aerosolized B. anthracis. This indication is based on a surrogate endpoint. Levofloxacin plasma concentrations achieved in humans are reasonably likely to predict clinical benefit [see Clinical Studies (14.9)]

  4 The safety of levofloxacin in pediatric patients for durations of therapy beyond 14 days has not been studied. An increased incidence of musculoskeletal adverse events compared to controls has been observed in pediatric patients [see Warnings and Precautions (5.10), Use in Specific Populations (8.4), and Clinical Studies (14.9)]. Prolonged levofloxacin therapy should only be used when the benefit outweighs the risk.

  5 Drug administration should begin as soon as possible after suspected or confirmed exposure to Yersinia pestis.

  Type of Infection1 Dose Freq. Once
  every Duration2 Inhalational Anthrax (post-exposure)3,4     Pediatric Patients > 50 kg
  
  500 mg 24hr 60 days4     Pediatric Patients < 50 kg
      and ≥ 6 months of age 8 mg/kg
  (not to exceed
  250 mg per dose) 12hr 60 days4 Plague5
      Pediatric Patients > 50 kg
  
  500 mg
  24hr 10 to 14 days     Pediatric Patients < 50 kg
      and ≥ 6 months of age 8 mg/kg
  (not to exceed
  250 mg per dose) 12hr 10 to 14 days 2.3 Dosage Adjustment in Adults with Renal Impairment

  Administer levofloxacin with caution in the presence of renal insufficiency. Careful clinical observation and appropriate laboratory studies should be performed prior to and during therapy since elimination of levofloxacin may be reduced.

  No adjustment is necessary for patients with a creatinine clearance ≥ 50 mL/min.

  In patients with impaired renal function (creatinine clearance <50 mL/min), adjustment of the dosage regimen is necessary to avoid the accumulation of levofloxacin due to decreased clearance [see Use in Specific Populations (8.6)].

  Table 3 shows how to adjust dose based on creatinine clearance.

  Table 3: Dosage Adjustment in Adult Patients with Renal Impairment (creatinine clearance <50 mL/min) Dosage in Normal Renal
  Function Every 24 hours Creatinine Clearance
  20 to 49 mL/min Creatinine Clearance
  10 to 19 mL/min Hemodialysis or Chronic
  Ambulatory Peritoneal
  Dialysis (CAPD) 750 mg 750 mg every 48 hours 750 mg initial dose, then
  500 mg every 48 hours 750 mg initial dose, then
  500 mg every 48 hours 500 mg 500 mg initial dose, then
  250 mg every 24 hours 500 mg initial dose, then
  250 mg every 48 hours 500 mg initial dose, then
  250 mg every 48 hours 250 mg No dosage adjustment
  required 250 mg every 48 hours. If
  treating uncomplicated
  UTI, then no dosage
  adjustment is required No information on dosing
  adjustment is available 2.4 Drug Interaction With Chelation Agents: Antacids, Sucralfate, Metal Cations, Multivitamins

  Levofloxacin Injection

  Levofloxacin Injection should not be co-administered with any solution containing multivalent cations, e.g., magnesium, through the same intravenous line [see Dosage and Administration (2.6)].

  2.5 Administration Instructions

  Levofloxacin Injection

  Caution: Rapid or bolus intravenous infusion of levofloxacin has been associated with hypotension and must be avoided. Levofloxacin Injection should be infused intravenously slowly over a period of not less than 60 or 90 minutes, depending on the dosage. Levofloxacin Injection should be administered only by intravenous infusion. It is not for intramuscular, intrathecal, intraperitoneal, or subcutaneous administration.

  Hydration for Patients Receiving Levofloxacin Injection

  Adequate hydration of patients receiving intravenous levofloxacin should be maintained to prevent the formation of highly concentrated urine. Crystalluria and cylindruria have been reported with quinolones [see Adverse Reactions (6.1) and Patient Counseling Information (17.2)].

  2.6 Preparation of Intravenous Product

  Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

  Because only limited data are available on the compatibility of Levofloxacin Injection with other intravenous substances, additives or other medications should not be added to Levofloxacin Injection Premix in Single-Use Flexible Containers, or infused simultaneously through the same intravenous line. If the same intravenous line is used for sequential infusion of several different drugs, the line should be flushed before and after infusion of Levofloxacin Injection with an infusion solution compatible with Levofloxacin Injection and with any other drug(s) administered via this common line.

  Levofloxacin Injection Premix in Single-Use Flexible Containers (5 mg/mL)

  Levofloxacin Injection is supplied in flexible containers within a foil overwrap. These contain a premixed, ready to use levofloxacin solution in 5% dextrose (D5W) for single-use. The 100 mL premixed flexible containers contain either 250 mg/50 mL or 500 mg/100 mL of levofloxacin solution. The 150 mL flexible container contains 750 mg/150 mL of levofloxacin solution. The concentration of each container is 5 mg/mL. No further dilution of these preparations is necessary. Because the premix flexible containers are for single-use only, any unused portion should be discarded.

  Instructions for the Use of Levofloxacin Injection Premix in Flexible Containers:

  Tear outer wrap at the notch and remove solution container. Check the container for minute leaks by squeezing the inner bag firmly. If leaks are found, or if the seal is not intact, discard the solution, as the sterility may be compromised. Do not use if the solution is cloudy or a precipitate is present. Use sterile equipment. WARNING: Do not use flexible containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is complete.

  Preparation for Administration:

  Close flow control clamp of administration set. Remove cover from port at bottom of container. Insert piercing pin of administration set into port with a twisting motion until the pin is firmly seated. NOTE: See full directions on administration set carton. Suspend container from hanger. Squeeze and release drip chamber to establish proper fluid level in chamber during infusion of Levofloxacin Injection Premix in Flexible Containers. Open flow control clamp to expel air from set. Close clamp. Regulate rate of administration with flow control clamp.

  Close
  No Recall

  More Info
• Meijer Distribution Inc
  

  ×

  Nitetime Cold And Flu | Meijer Distribution Inc

  

  ---

  • take only as directed – see Liver warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  • when using other Daytime or Nighttime products, carefully read each label to insure correct dosing

  Close
  No Recall

  More Info
• Meijer Distribution Inc
  

  ×

  Nitetime Cold And Flu | Meijer Distribution Inc

  

  ---

  • take only as directed - see Overdose warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  Close
  No Recall

  More Info